EBVB

EBVB — the European Biotech Venture Builder — takes scientific innovation from the laboratory to the market, building healthcare companies around eHealth technologies, new therapeutic entities, advanced therapies and synthetic biology. It has been selected by the European Innovation Council and SMEs Executive Agency as a reference venture builder in the European biotech ecosystem.

The brief was to explain a business model that sits between science, industry and investment, for an audience of researchers, investors and corporations. The client provided the recorded material and we handled the editing and motion graphics.

The graphic work carries most of the explanatory load: it structures the drug development process, makes the stages of the model visible and keeps the pace steady in a piece with a high density of information.

It is the same approach we apply to scientific communication — respect the technical content and make the structure legible — brought here to a business audience.